Novavax
NVAX
#5417
Rank
A$1.92 B
Marketcap
A$11.80
Share price
-4.26%
Change (1 day)
14.91%
Change (1 year)

Novavax (NVAX) - Total assets

Total assets on the balance sheet as of December 2025 : A$1.71 Billion

According to Novavax's latest financial reports the company's total assets are A$1.71 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Novavax - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2025-12-31A$1.75 B-29.98%
2024-12-31A$2.50 B-4.91%
2023-12-31A$2.63 B-20.51%
2022-12-31A$3.31 B-6.61%
2021-12-31A$3.55 B72.7%
2020-12-31A$2.05 B733.1%
2019-12-31A$0.24 B-16.32%
2018-12-31A$0.29 B-23.81%
2017-12-31A$0.38 B-29.17%
2016-12-31A$0.54 B3.23%
2015-12-31A$0.52 B57.13%
2014-12-31A$0.33 B27.94%
2013-12-31A$0.26 B167.65%
2012-12-31A$98.48 M51.68%
2011-12-31A$64.93 M-11.88%
2010-12-31A$73.68 M-22.68%
2009-12-31A$95.29 M-12.26%
2008-12-31A$0.10 B4.01%
2007-12-31A$0.10 B-32.46%
2006-12-31A$0.15 B34.06%
2005-12-31A$0.11 B14.42%
2004-12-31A$0.10 B-10.99%
2003-12-31A$0.11 B10.93%
2002-12-31A$0.10 B-22.39%
2001-12-31A$0.13 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Novartis
NVS
A$161.83 B 9,330.35%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$303.63 B 17,593.01%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$166.39 B 9,595.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$120.06 B 6,896.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
A$4.88 B 184.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A$0.85 B-50.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$0.34 B-80.12%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
A$12.19 M-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A$0.74 B-56.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$2.13 B 24.18%๐Ÿ‡บ๐Ÿ‡ธ USA